According to a recent analysis conducted by Ciampi et al. on one of the largest series in the literature [8], the average prevalence of RAS mutations in sporadic MTC is around 8.8%, and these authors confirmed that RET and RAS mutations were mutually exclusive. This evidence concerns the gene RET and medullary thyroid gland carcinoma.